<DOC>
	<DOCNO>NCT01069939</DOCNO>
	<brief_summary>To assess efficacy D961H 20 mg daily ( q.d . ) versus placebo continuous treatment involve patient history gastric and/or duodenal ulcer receive daily Low-dose aspirin therapy evaluate time randomisation occurrence gastric and/or duodenal ulcer .</brief_summary>
	<brief_title>Comparative Efficacy &amp; Safety Study D961H Versus Placebo Prevention Gastric Duodenal Ulcers With Low-dose Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Provision write informed consent start studyrelated procedure examination Patients history gastric and/or duodenal ulcer . A diagnosis chronic condition ( angina pectoris , myocardial infarction ischemic cerebrovascular disorder , etc. , require prevention thrombosis embolism ) require take prescribe LDA study treatment period . Having gastric duodenal ulcer ( except ulcer scar ) . History esophageal , gastric duodenal surgery , except simple closure perforation .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Gastric ulcer</keyword>
	<keyword>Duodenal ulcer</keyword>
	<keyword>Low-dose aspirin</keyword>
</DOC>